Entering text into the input field will update the search result below

PEY: Steady Double-Digit Total Return Over A Longer Time Horizon

Summary

  • PEY's annual yield has consistently ranged between 3 and 4 percent.
  • PEY's investment in basic sectors are less volatile, and less likely to be impacted by an economic downturn.
  • PEY generated price growth between 9 and 15 percent over the medium and long term.
  • Looking for more investing ideas like this one? Get them exclusively at The Total Pharma Tracker. Learn More »

Evening view of Ama Dablam

DanielPrudek/iStock via Getty Images

The Invesco High Yield Equity Dividend Achievers ETF (NASDAQ:PEY) is an exchange traded fund launched and managed by Invesco Capital Management LLC. The fund has an asset under management (AUM) over $1.14 billion

About the TPT service

Thanks for reading. At the Total Pharma Tracker, we offer the following:-


Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curated research material. 

For investors requiring hands-on support, our in-house experts go through our tools and find the best investible stocks, complete with buy/sell strategies and alerts.

Sign up now for our free trial, request access to our tools, and find out, at no cost to you, what we can do for you. 



This article was written by

Avisol Capital Partners profile picture
17.32K Followers

Avisol Capital Partners is made up of a team of medical experts, finance professionals and techies, all of whom invest their own money in the picks they share. They aim to help readers find the middle ground between value and growth investing, as they demystify the biopharma industry.

They lead the investing group Total Pharma Tracker where they offer a monthly updated catalyst database, an investability scoring system for quick reference ideas, and direct access in chat for dialogue and questions. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (5)

e
Don't forget about SPHD for income as it pays a monthly dividend.
T
I like SCHD. Better total return and Expense Ratio of 0.06% compared to 0.53%. Plus, no tobacco.
Eileen Dover profile picture
@Tough Enough SA authors keep telling us over and over that expense ratios are meaningless as the noted yield is what you get after those expenses. Owning tobacco does not mean you are investing in it, just that you are possibly benefiting from holding it. Any stock you hold are bought from another stockholder so the company doesn't benefit.
F
Im long in PEY in my ROTH,but I pair it with SCHD.
D
Interesting article! This could make a good core holding. Thanks for the info
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About PEY

SymbolLast Price% Chg
Expense Ratio
Div Frequency
Div Rate (TTM)
Yield (TTM)
Assets (AUM)
Compare to Peers

More on PEY

Related Stocks

SymbolLast Price% Chg
PEY
--
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.